Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589797 · ClinicalTrials.gov registry record · NA
Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease
A NA study of Degenerative Disc Disease, sponsored by Aesculap Implant Systems.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
- 17
- Study locations
NCT00589797: Completed NA study of Degenerative Disc Disease, sponsored by Aesculap Implant Systems.
NCT00589797 is a NA study of Degenerative Disc Disease that has completed, run by Aesculap Implant Systems. The registered enrollment target is 376 participants, above the 160-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (135% higher). The trial reports 17 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589797, a NA study of Degenerative Disc Disease, has completed, sponsored by Aesculap Implant Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this study is to learn whether an investigational device called the Activ-L Artificial Disc is safe and effective in the treatment of degenerative disc disease of the lower (lumbar) spine.
Primary Outcome
Measured by absence of treatment failure; absence or serious device related AE; maintenance or improvement of ROM at index level; maintenance or improvement of neurological status; improvement in ODI score.
Conditions Studied
Interventions
- DEVICE Activ-L Artificial Disc
- DEVICE ProDisc-L Total Disc Replacement or Charité Artificial Disc
Study Locations (17)
California
- Scripps Memorial Hospital La Jolla - La Jolla
- Hoag Memorial Hospital Presbyterian - Newport Beach
- Rancho Specialty Hospital - Rancho Cucamonga
- University of California San Francisco - San Francisco
- St. John's Hospital and Health Center - Santa Monica
Florida
- Aventura Hospital and Medical Center - Aventura
- University Community Hospital - Tampa
Illinois
- Rush University Medical Center - Chicago
- Neurosciences Education and Research Foundation - Peoria
Colorado
- University of Colorado Health Sciences Center - Aurora
Connecticut
- Yale University School of Medicine/New Haven Hospital - New Haven
Minnesota
- HealthEast St. John's Hospital - Maplewood
New York
- Hospital for Special Surgery - New York
North Carolina
- Carolinas Healthcare - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2007-01 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT00589797 record still lists
NCT00589797 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, above the 160-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (135% higher).
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Activ-L Artificial Disc is the first listed.
NCT00589797 lists 17 locations in 11 states (California, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT00589797 about?
NCT00589797 is a clinical study titled "Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease". The purpose of this study is to learn whether an investigational device called the Activ-L Artificial Disc is safe and effective in the treatment of degenerative disc disease of the lower (lumbar) spine.
What is the current status of trial NCT00589797?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2007-01. Estimated completion is 2017-01.
What conditions does trial NCT00589797 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT00589797?
The interventions under investigation include: Activ-L Artificial Disc (DEVICE), ProDisc-L Total Disc Replacement or Charité Artificial Disc (DEVICE).
Who is sponsoring clinical trial NCT00589797?
This trial is sponsored by Aesculap Implant Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00589797 being conducted?
This trial has 17 study locations across California, Colorado, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00589797's enrollment target sits among peer trials
376 5th of 42 higher than 38 of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia